Efficacy of immune checkpoint inhibitors in different types of melanoma

Efficacy of immune checkpoint inhibitors in different types of melanoma

Immunotherapy can be used for cutaneous, mucosal, uveal and conjunctival melanoma. Nevertheless, we cannot expect the same benefit from checkpoint inhibitors for all the types of melanoma. The different biological features can explain the variable efficacy. The main results obtained with immune chec...

Full description

Bibliographic Details
Main Authors: Ernesto Rossi, Giovanni Schinzari, Brigida Anna Maiorano, Giulia Indellicati, Alessandro Di Stefani, Monica Maria Pagliara, Simona Maria Fragomeni, Erika Valentina De Luca, Maria Grazia Sammarco, Giorgia Garganese, Jacopo Galli, Maria Antonietta Blasi, Gaetano Paludetti, Giovanni Scambia, Ketty Peris, Giampaolo Tortora
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
immunotherapy
melanoma
uveal melanoma
conjunctival melanoma
Online Access:http://dx.doi.org/10.1080/21645515.2020.1771986

Internet

http://dx.doi.org/10.1080/21645515.2020.1771986

Similar Items